Wilmer Cutler Pickering Hale and Dorr represented Mountaingate Capital in the transaction. Mountaingate Capital (“Mountaingate”), a private equity firm specializing in partnering with founders and entrepreneurial...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Thermo Fisher Scientific Inc. on the transaction, and Cleary Gottlieb Steen & Hamilton advised Solventum. Solventum announced the definitive...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented CH Investment Partners in the transaction. Cresset Asset Management (“Cresset”) , an independent investment firm, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented TechTarget, Inc. in the transaction, and Clifford Chance represented Informa PLC. TechTarget, Inc. (NASDAQ: TTGT) and Informa PLC (LSE:...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Lilly, while Wilmer Cutler Pickering Hale and Dorr represented Akouos in the transaction. Eli Lilly and Company (NYSE: LLY) announced its acquisition...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised WEX, Inc. on the deal. WEX, Inc., a leading financial technology service provider, announced the signing of an...
You must be a Standard 1 Year member to access this content.
